Denial Reason
Experimental Treatment Denied
Your insurer classified your treatment as experimental, investigational, or not yet proven standard of care. This classification is often incorrect — many treatments accepted by specialists are labelled experimental by insurers to avoid payment.
52%
Appeal success rate
NAIC 2022
52%
External review overturn
NAIC data
What Strengthens Your Appeal
- ✓Published clinical guidelines from relevant specialty societies showing the treatment is accepted medical practice
- ✓FDA approval or clearance for the indication being treated
- ✓Level I or II clinical evidence (randomized controlled trials, meta-analyses) supporting the treatment
- ✓NCCN guidelines, AHA/ACC guidelines, ASCO guidelines, or equivalent specialty society endorsements
- ✓Evidence that the treatment is offered by major academic medical centers as standard practice
- ✓Peer-reviewed publications in major journals (NEJM, Lancet, JAMA, JAMA Oncology) supporting the treatment
Appeal Packet: What to Include
- 1Denial letter with the insurer's specific experimental determination
- 2Insurer's clinical policy bulletin showing their evidence standard
- 3Your physician's Letter of Medical Necessity with literature citations
- 4Relevant clinical guidelines (NCCN, AHA, ASCO, specialty societies)
- 5Peer-reviewed journal articles showing effectiveness and acceptance
- 6Evidence of FDA approval or clearance
- 7Documentation that major cancer centers or academic hospitals offer this as standard treatment
What to Ask Your Doctor or Provider
Your provider plays a key role in your appeal. Ask them for:
- →A Letter of Medical Necessity specifically addressing the experimental treatment classification
- →Clinical literature citations showing this is accepted standard of care in the specialty
- →Documentation of published guidelines and professional society endorsements
- →A summary of clinical outcomes data supporting the treatment for your diagnosis
Step-by-Step Escalation
If your first appeal fails: Request external review — this is particularly strong for experimental treatment denials because external reviewers are required to be specialists with expertise in the relevant field. They frequently disagree with insurer experimental classifications when strong clinical evidence exists.
1
File internal appeal with comprehensive clinical evidence package
Deadline: Within 180 days
2
Request external review with a physician specialist in the relevant area
Deadline: Within 4 months of internal denial
3
File state insurance department complaint — some states have 'any willing provider' cancer treatment laws
Find your regulator →4
Consult healthcare attorney for high-value cases (cancer treatment, gene therapy, etc.)
Deadline: Varies
Procedure-Specific Experimental Treatment Guides
Related Denial Reasons
🛡️
Fight This Denial
Generate a professional appeal letter in minutes. Tailored to Experimental Treatment denials.
Generate Appeal Letter →Free · No signup required